This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2009 Dec;27(12):1082-4.

doi: 10.1038/nbt1209-1082.

Medicare formulary coverage for top-selling biologics

Su-Ying Liang, Jennifer S Haas, Kathryn A Phillips

PMID: 20010576
PMCID: PMC2845541
DOI: 10.1038/nbt1209-1082

Medicare formulary coverage for top-selling biologics

Su-Ying Liang et al. Nat Biotechnol. 2009 Dec.

. 2009 Dec;27(12):1082-4.

doi: 10.1038/nbt1209-1082.

Authors

Su-Ying Liang, Jennifer S Haas, Kathryn A Phillips

PMID: 20010576
PMCID: PMC2845541
DOI: 10.1038/nbt1209-1082

No abstract available

PubMed Disclaimer

Similar articles

Access to cancer drugs in Medicare Part D: formulary placement and beneficiary cost sharing in 2006.
Bowman J, Rousseau A, Silk D, Harrison C. Bowman J, et al. Health Aff (Millwood). 2006 Sep-Oct;25(5):1240-8. doi: 10.1377/hlthaff.25.5.1240. Health Aff (Millwood). 2006. PMID: 16966719
Coverage for hepatitis C drugs in Medicare Part D.
Jung JK, Feldman R, Cheong C, Du P, Leslie D. Jung JK, et al. Am J Manag Care. 2016 May;22(6 Spec No.):SP220-6. Am J Manag Care. 2016. PMID: 27266952 Free PMC article.
Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis.
Tseng CW, Dudley RA, Chen R, Walensky RP. Tseng CW, et al. JAMA Netw Open. 2020 Apr 1;3(4):e202739. doi: 10.1001/jamanetworkopen.2020.2739. JAMA Netw Open. 2020. PMID: 32286656 Free PMC article.
Medicare part D: selected issues for plan sponsors, pharmacists, and beneficiaries in 2008.
Depue R, Stubbings J. Depue R, et al. J Manag Care Pharm. 2008 Jan-Feb;14(1):50-60. doi: 10.18553/jmcp.2008.14.1.50. J Manag Care Pharm. 2008. PMID: 18240882 Free PMC article. Review.
Medicare Part D: practical practice information for healthcare providers.
Moczygemba LR. Moczygemba LR. J Am Acad Nurse Pract. 2006 Oct;18(10):457-62. doi: 10.1111/j.1745-7599.2006.00162.x. J Am Acad Nurse Pract. 2006. PMID: 16999710 Review.

See all similar articles

Cited by

Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval.
Shaw DL, Dhruva SS, Ross JS. Shaw DL, et al. J Manag Care Spec Pharm. 2018 Dec;24(12):1230-1238. doi: 10.18553/jmcp.2018.24.12.1230. J Manag Care Spec Pharm. 2018. PMID: 30479199 Free PMC article.
The Inclusion of Economic Endpoints as Outcomes in Clinical Trials Reported to ClinicalTrials.gov.
Mitchell JM, Patterson JA. Mitchell JM, et al. J Manag Care Spec Pharm. 2020 Apr;26(4):386-393. doi: 10.18553/jmcp.2020.26.4.386. J Manag Care Spec Pharm. 2020. PMID: 32223593 Free PMC article.
Variability in drug formularies and implications in decision support.
Stephens MJ, Finnell JT, Simonaitis L, Overhage JM. Stephens MJ, et al. AMIA Annu Symp Proc. 2011;2011:1327-36. Epub 2011 Oct 22. AMIA Annu Symp Proc. 2011. PMID: 22195194 Free PMC article.
A review of approaches for the management of specialty pharmaceuticals in the United States.
Patel BN, Audet PR. Patel BN, et al. Pharmacoeconomics. 2014 Nov;32(11):1105-14. doi: 10.1007/s40273-014-0196-0. Pharmacoeconomics. 2014. PMID: 25118989 Free PMC article. Review.
Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D.
Yazdany J, Dudley RA, Chen R, Lin GA, Tseng CW. Yazdany J, et al. Arthritis Rheumatol. 2015 Jun;67(6):1474-80. doi: 10.1002/art.39079. Arthritis Rheumatol. 2015. PMID: 25900105 Free PMC article.

See all "Cited by" articles

References

1. Adams KT. Biologics and Benefit Design: What's New for '06? Biotechnology Healthcare. 2006 February;3(1):28–35. - PMC - PubMed
1. Mullins CD, Lavallee DC, Pradel FG, DeVries AR, Caputo N. Health plans’ strategies for managing outpatient specialty pharmaceuticals. Health Aff (Millwood) 2006 Sep-Oct;25(5):1332–1339. - PubMed
1. Robinson JC. Insurers’ strategies for managing the use and cost of biopharmaceuticals. Health Aff (Millwood) 2006 Sep-Oct;25(5):1205–1217. - PubMed
1. Tseng CW, Mangione CM, Brook RH, Keeler E, Dudley RA. Identifying widely covered drugs and drug coverage variation among Medicare part D formularies. JAMA. 2007 Jun 20;297(23):2596–2602. - PubMed
1. Bowman J, Rousseau A, Silk D, Harrison C. Access to cancer drugs in Medicare Part D: formulary placement and beneficiary cost sharing in 2006. Health Aff (Millwood) 2006 Sep-Oct;25(5):1240–1248. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information